Event Details

EBMT 2023 Presentation

Apr 26, 2023 at 10:48 AM CEST
Final Clinical and Biomarker Data from a Phase 2 Trial of Posoleucel, an Off-The-Shelf, Multi-Virus-Specific T-Cell Therapy, for Prevention of Clinically Significant Viral Infections Post-HCT